It has been reported that the Mayo Clinic in Jacksonville, Florida has slots in a trial with the Merck anti-PD1 product. There are openings for both prior ipi (Yervoy) use, as well as for patients who are ipi naive. Call for an appointment or more information if you are interested!
Also in anti-PD1 news: A BMS phase III anti-PD1 trial should be enrolling soon. That is great news, since they will have skipped the Phase II portion. The downside is that now, the trial will be randomized and the comparison treatment is yet to be announced. Addtionally, the trial is to be an international one with limited slots in comparison to the number of patients in need...but it is progress. Will post any additonal information as I acquire it. - c
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment